Taiwan FDA registration 053c8393d781ed30559727bbaf32609d
Martin Peter Free Tetraiodothyroxine Test System
TW: 馬丁彼得游離四碘甲狀腺素試驗系統
Taiwan·Risk Class 2·MP BIOMEDICALS DIAGNOSTICS DIVISION·Registered May 08, 2006 – May 08, 2021CancelledRegistration details
- Analysis ID
- 053c8393d781ed30559727bbaf32609d
- Customs Code
- DHAS0601655500
Company information
- Manufacturer
- MP BIOMEDICALS DIAGNOSTICS DIVISION
- Manufacturer Country
- United States
- Authorized Representative
- GENERAL BIOLOGICALS CORP.
Product details
- Intended Use
- Quantitative detection of the concentration of free tetraiodothyroxine in human serum and plasma.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1695 游離甲狀腺素試驗系統
- Import Information
- Consent must be attached to the import (with the consent of the Atomic Energy Commission must be obtained for each import); input
Dates and status
- Registration Date
- May 08, 2006
- Expiry Date
- May 08, 2021
- Cancellation Date
- Aug 15, 2023
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Martin Peter Free Tetraiodothyroxine Test System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 053c8393d781ed30559727bbaf32609d and manufactured by MP BIOMEDICALS DIAGNOSTICS DIVISION. The authorized representative in Taiwan is GENERAL BIOLOGICALS CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices